Start with its own history
At 17.56×, MKKGY is 33.0% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
OTC · MKKGYDrug Manufacturers - Specialty & GenericUpdated Nov 5, 2026
Merck KGaA P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
17.56×
33.0% belowthe 10-year annual average
Share price34.06
÷Earnings per share1.94
Price and EPS in quote currency. Calculation details
Investors are paying 17.56 for every 1 of reported earnings per share.
P/E over time
2016 – 2025
Annual P/ESelected-period average 26.20×
3-year average21.50×3 positive annual observations
5-year average24.09×5 positive annual observations
10-year average26.20×10 positive annual observations
Peer median · TTM38.39×7 peers with positive P/E
Historical P/E ratios
Annual period-end data · 19 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2025 | 20.43× | -6.7% |
| Dec 31, 2024 | 21.89× | -1.2% |
| Dec 31, 2023 | 22.17× | -6.2% |
| Dec 31, 2022 | 23.65× | -26.8% |
| Dec 31, 2021 | 32.29× | +5.1% |
| Dec 31, 2020 | 30.71× | -11.4% |
| Dec 31, 2019 | 34.65× | -0.3% |
| Dec 31, 2018 | 34.76× | +132.0% |
View all 19 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2017 | 14.98× | -43.3% |
| Dec 31, 2016 | 26.44× | -24.4% |
| Dec 31, 2015 | 34.99× | +18.7% |
| Dec 31, 2014 | 29.48× | +25.4% |
| Dec 31, 2013 | 23.51× | -39.3% |
| Dec 31, 2012 | 38.74× | +40.8% |
| Dec 31, 2011 | 27.51× | +34.3% |
| Dec 31, 2010 | 20.49× | -47.2% |
| Dec 31, 2009 | 38.79× | +2.2% |
| Dec 31, 2008 | 37.95× | +604.0% |
| Dec 31, 2007 | 5.39× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How MKKGY compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 MKKGY This stockMerck KGaA | 17.56× |
 TECHBio-Techne Corporation | 62.16× |
 BIOBio-Rad Laboratories, Inc. | 9.96× |
 DHRDanaher Corporation | 38.39× |
 TMOThermo Fisher Scientific Inc. | 37.19× |
 RVTYRevvity, Inc. | 70.54× |
 AAgilent Technologies, Inc. | 34.81× |
 WATWaters Corporation | 198.98× |
 LZAGYLonza Group AG | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does MKKGY’s P/E tell you?
Compare like with like
The median of the 7 positive peer ratios above is 38.39×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take MKKGY into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("MKKGY", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 34.06 ÷ EPS 1.94 = 17.56×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 5, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
MKKGY P/E ratio: common questions
The essentials behind the numbers.
Merck KGaA's current P/E is 17.56× based on the quote data last updated Nov 5, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.